Justin Amash and Steve Womack Just Set a New Record in Congress

The Republican lawmakers have pristine voting records.

Emma Roller
May 30, 2014, 11:51 a.m.

Late Thursday night, Re­pub­lic­an Reps. Justin Amash of Michigan and Steve Womack of Arkan­sas passed a mile­stone. They each cast their 2,500th vote in the House of Rep­res­ent­at­ives — giv­ing them both the longest con­tinu­ous vot­ing streak among their cur­rent col­leagues in the House.

Amash, who was elec­ted in the 2010 wave of tea-party can­did­ates, pub­lished a short cel­eb­rat­ory Face­book post about the bench­mark Thursday night. “I just cast my 2,500th straight vote in Con­gress without hav­ing missed a vote. That’s the longest act­ive vote streak of any rep­res­ent­at­ive,” he said.

Since last night’s round of votes, Amash and Womack have now each racked up 2,520 con­sec­ut­ive roll-call votes. By com­par­is­on, the av­er­age rep­res­ent­at­ive has missed 2.4 per­cent of votes over their time in of­fice. “I’m honored to set an ex­ample as a con­gress­man who votes every time and ex­plains every vote,” Amash said in a state­ment to Na­tion­al Journ­al.

“Third Dis­trict Arkansans en­trus­ted me with the re­spons­ib­il­ity to rep­res­ent them in the U.S. House of Rep­res­ent­at­ives — that means show­ing up to vote,” Womack said in a state­ment to Na­tion­al Journ­al. “I am grate­ful that noth­ing has pre­ven­ted me from do­ing so and for the hon­or of be­ing my con­stitu­ents’ voice and an ex­ample for my peers.”

On the Sen­ate side, Re­pub­lic­an Sen. Susan Collins of Maine has not missed a single vote since she was elec­ted in 1997, and has cast 5,530 con­sec­ut­ive votes. For­tu­nately for Amash and Womack, none of their more-seni­or col­leagues have such ster­ling at­tend­ance re­cords.

This post has been up­dated to in­clude Rep. Steve Womack’s share of the vote at­tend­ance re­cord.

What We're Following See More »
DRUG OFFENDERS
Obama Grants 111 More Commutations
11 hours ago
THE DETAILS

In a release Tuesday afternoon, the White House announced that President Obama has commuted and/or reduced the sentences of another 111 convicted criminals, mostly convicted of drug possession or trafficking. About 35 were serving life sentences.

BUT HE’S NOT ADVOCATING FOR IT
Grassley Open to Lame Duck Hearings on Garland
12 hours ago
THE LATEST

Senate Judiciary Committee Chairman Chuck Grassley (R-IA) said Monday he'd now be willing to hold a hearing on Supreme Court nominee Merrick Garland in a lame-duck session of Congress. While he said he wouldn't push for it, he said if "Hillary Clinton wins the White House, and a majority of senators convinced him to do so," he would soften his previous opposition.

Source:
DOWN FROM POST-CONVENTION NUMBERS
Monmouth Has Clinton Up Seven
16 hours ago
THE LATEST

In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.

Source:
DEBATE PREP
Clinton Advisers Talking to Psychologists, Trump Ghostwriter
17 hours ago
THE LATEST

“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”

EPI-PEN PRICES
House Committee Investigating Mylan
19 hours ago
THE LATEST

The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.

Source:
×